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Abstract
Background: A large proportion of pregnancy losses occur during the pre-implantation period, when the
developing embryo is elongating rapidly and signalling its presence to the maternal system. The molecular
mechanisms that prevent luteolysis and support embryo survival within the maternal environment are not well
understood. To gain a more complete picture of these molecular events, genome-wide transcriptional profiles of
reproductive day 17 endometrial tissue were determined in pregnant and cyclic Holstein-Friesian dairy cattle.
Results: Microarray analyses revealed 1,839 and 1,189 differentially expressed transcripts between pregnant and
cyclic animals (with ≥ 1.5 fold change in expression; P-value < 0.05, MTC Benjamini-Hochberg) in caruncular and
intercaruncular endometrium respectively. Gene ontology and biological pathway analysis of differentially
expressed genes revealed enrichment for genes involved in interferon signalling and modulation of the immune
response in pregnant animals.
Conclusion: The maternal immune system actively surveys the uterine environment during early pregnancy. The
embryo modulates this response inducing the expression of endometrial molecules that suppress the immune
response and promote maternal tolerance to the embryo. During this period of local immune suppression, genes
of the innate immune response (in particular, antimicrobial genes) may function to protect the uterus against
infection.
Background
Over the past three decades, there has been a coinciden-
tal decline in fertility associated with genetic selection
for increased milk production. It is estimated that
approximately 50% of the potential profitability from
genetic selection for milk production is lost due to a
reduction in fertility [1].
The fertilisation rate for lactating dairy cattle is
around 90% and does not differ between low-moderate
and high-producing animals when managed under pas-
toral conditions[2]. However, the calving rate in lower
producing animals is approximately 55%, whereas for
high-producing animals, this rate is approximately 35%
[2]. Pregnancy losses are thought to occur primarily
during the pregnancy recognition/pre-implantation per-
iod [2], making studies of endometrial gene expression
critical to further understanding of pregnancy
establishment, recognition and maintenance within the
bovine reproductive cycle.
Successful pregnancy in mammals requires both a
viable embryo and a receptive endometrium. Synchro-
nous signalling between the endometrium and embryo
during the pre-implantation period is critical for normal
embryo development, implantation of the embryo, and
placentation [3]. The early embryo is nourished by
secretions (histotroph) from the uterine glands (intercar-
uncular endometrium) and during implantation forms a
close physical association (attachment) with the carun-
cular endometrium [4]. Pregnancy thus represents an
immunological contradiction, in that the immunologi-
cally foreign embryo is able to form a close physical
relationship with the maternal endometrium that lasts
throughout pregnancy. Under normal circumstances, a
foreign tissue would likely be rejected by the recipient
unless the immune system was significantly suppressed
or tolerant to the tissue. That the embryo can survive in
the presence of the maternal immune system has lead * Correspondence: Caroline.Walker@dairynz.co.nz
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privileged site [5].
Several mechanisms have been proposed to account
for the ability of the embryo to survive in the maternal
environment including: antigenic immaturity of the con-
ceptus (the bovine trophoblast, like other mammalian
species, does not express classical polymorphic major
histocompatibility complex (MHC) class 1 proteins in
areas in contact with the maternal endometrium during
early pregnancy [5]) and maternal immunological inert-
ness to the conceptus or localised immune tolerance [6].
Local immunosuppression, required for establishment
and maintenance of pregnancy, would leave the uterus
vulnerable to infection. An increase in innate immune
activity may be expected to protect the uterus from
infection.
The aim of this study was to identify molecules and
pathways involved in pregnancy recognition and mainte-
nance and, in particular to characterise the local
immune response that occurs in the endometrium as a
consequence of pregnancy. The transcriptional response
to the presence of an embryo was characterised during
the pre-implantation period in dairy cows. Novel mole-
cules and pathways potentially involved in mechanisms
the embryo uses to evade the maternal immune system
were identified.
Results
Differentially expressed genes
Microarray analyses revealed 1,839 and 1,189 differen-
tially expressed transcripts between pregnant and cyclic
animals (with ≥ 1.5 fold change in expression; P-value <
0.05, MTC Benjamini-Hochberg) in caruncular and
intercaruncular endometrium respectively (Additional
file 1, Table S1). The majority of transcripts were up-
regulated in pregnant animals (1027 in caruncular, 633
in intercaruncular). Some genes were differentially
expressed between pregnant and cyclic animals in either
the caruncular or intercaruncular tissues. Of these, 1027
(480 up-regulated in pregnant) differentially expressed
transcripts were identified in caruncular endometrium
only, and a further 377 (86 up-regulated in pregnant)
differentially expressed transcripts were identified only
in intercaruncular tissue (Figure 1).
Molecular and biological function and pathway analysis
Ingenuity pathway analysis (IPA) revealed molecular
networks and pathways associated with genes that were
differentially expressed in pregnant versus cyclic ani-
mals. 1,499 individual genes were contained within the
Ingenuity database and were used for analysis. The four
most statistically significant canonical pathways identi-
fied by IPA were interferon signalling (Figure 2), com-
plement system (Figure 3), Role of pattern recognition
receptors in the recognition of bacteria and viruses, and
antigen presentation (Additional file 2, Table S2). The
networks generated by IPA that contained the most sig-
nificant number of genes with direct relationships
(molecules that directly affect one another) were:
- Network 1 - Cell death, hematological disease,
immunological disease (score = 49, 28 molecules)
- Network 2 - Infection mechanism, antimicrobial
response, cell signaling (score = 45, 26 molecules)
- Network 3 - Infectious disease, cell morphology,
cellular assembly and organization (score = 43, 26
molecules)
- Network 4 - Cellular growth and proliferation,
connective tissue development and function, cell
cycle (score = 23, 16 molecules)
- Network 5 - Lipid metabolism, molecular trans-
port, small molecule biochemistry (score = 21, 15
molecules).
’Functional groups’ and biological processes associated
with pregnancy and estrous cycle progression (cycling
animals) in the dairy cow during the preimplantation
period were identified. Genes were assigned to molecular
and biological functions using the PANTHER (Protein
Analysis Through Evolutionary Relationships) classifica-
tion system (http://www.pantherdb.org/). The biological
process “immunity and defence” contained the most
genes for this analysis. (Additional file 3, Table S3).
Figure 1 Number of genes differentially expressed between
pregnant and cyclic animals in both and individual tissue
types. Genes with ≥ 1.5 fold change in expression; P-value < 0.05,
Benjamini-Hochberg MTC.
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microarray results
Relative qRT-PCR was used to confirm microarray
results. 5 genes of interest (OXTR, IDO, SPP1, OAS2,
and CXCL11) that were differentially expressed accord-
ing to microarray analysis were quantified, and the cor-
relation between qRT-PCR and microarray (Pearson
correlation coefficient) calculated exceeded 0.75 for all
genes tested (Table 1, Figure 4).
Discussion
Genes up-regulated in pregnant animals
In this study, endometrial expression profiles of day 17
pregnant and cyclic dairy cows were characterized and
several genes and pathways that were differentially
expressed between the two states were identified, pro-
viding insight into the molecular mechanisms active
during this time. Genes and pathways involved in the
maternal immune response to the presence of the
embryo appear to be particularly important in early
pregnancy, as these were some of the most up-regulated
genes in pregnant animals. The immune response to
pregnancy may be one of the key regulators of preg-
nancy maintenance, and deregulation of the immune
response may be responsible, at least in part, for the
large number of pregnancy losses that occur during this
time. Both innate and adaptive immune system genes
were differentially expressed during early pregnancy.
Many genes of the adaptive immune response that were
up-regulated may function to induce immune tolerance
Figure 2 Interferon signalling cascade. Genes differentially expressed between pregnant and cyclic dairy cows in the study reported are
shaded red (up-regulated in pregnant) and green (down-regulated in pregnant). The bovine embryo produces IFNτ which binds to type-1
interferon receptors, leading to the activation of the JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway and the
synthesis of a range of interferon stimulated gene products.
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Page 3 of 13Figure 3 Complement pathway. Genes up-regulated in pregnant dairy cows are shaded red. The complement system is part of the innate
immune response and can be activated in three ways: classical pathway, alternative pathway and lectin pathway, all of which converge at the
level of C3 convertase. The Classical pathway begins with activation of the C1 complex (6xC1q, 2xC1r and 2xC1s) through the binding of C1q to
antigen bound antibodies (IgG or IgM) or directly to the surface of a pathogen. Binding causes a conformational change in C1q which leads to
activation of C1r and C1s (serine proteases), this leads to cleavage of C4 and C2. The cleavage products of C4 and C2 form C3 convertase
cleaves C3, leading to the formation of C5 convertase that cleaves C5 and results in formation of the membrane attack complex [73].
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Page 4 of 13to the embryo, while genes of the innate immune
response (in particular, antimicrobial genes) may func-
tion to protect the uterus against infection during a
time of local immune suppression.
Immune response and interferon signalling
Interferon stimulated genes (ISG) were among the most
up-regulated group of genes in pregnant animals; this is
consistent with maximal production of the pregnancy
recognition signal interferon tau (IFNτ) by the embryo
during this time. The most statistically significant net-
works up-regulated in pregnant animals were involved
in the immune response, and immunity and defence
were identified as the most abundant gene ontology
terms.
Several ISGs were identified as being differentially
expressed in pregnant and cyclic animals, in agreement
with previous studies [7-11]. The current study, how-
ever, has identified several additional ISG not previously
identified in the bovine endometrium (Figure 2, Addi-
tional file 2, Table S2). Many of these genes may
function to provide localized immune system suppres-
sion to allow the embryo to survive within the uterus.
For example, IFITM1 has recently been demonstrated to
act as an immune suppressive molecule in gastric cancer
cells [12]. The upregulation of IFITM1 in cancer cells
was associated with an increase in migration and inva-
sive capacity, and its action in gastric tumour cells was
linked to suppression of NK cells [12]. Peptide Trans-
porter 1 (TAP-1) and TAP-2 were up-regulated in preg-
nant animals in agreement with another study [13]
along with MHC I A, and MHC I G. Upregulation of
TAP proteins may be involved in local immune suppres-
sion, as upregulation of TAP1 has been associated with
the capacity of natural killer cells to be non-cytotoxic
[14]. Kalkunte et al 2009 demonstrated that the non-
cytotoxic phenotype of uNK cells is achieved through
the expression of vascular endothelial growth factor-C
(VEGF-C), which enhances the resistance of trophoblast
and endothelial cells to lysis through induction of the
TAP-1 protein [14]. They reported that VEGF-C pro-
tected target endothelial and trophoblast cells from
cytotoxic NK cells directly through induction of TAP-1.
Additionally, in agreement with a local immune sup-
pression environment, IFIT1, OAS1 and OAS2 are up-
regulated in the autoimmune disease systemic lupus
[15]. OAS upregulation during early pregnancy is also
involved in regulating the production of osteopontin
(SPP1) [16,17], that was also up-regulated in pregnant
animals. Upregulation of SPP1 in pregnant animals may
have several functions, including promoting adhesion of
the trophoblast to the endometrium, stimulating mor-
phological changes in the trophoblast [18], and regulat-
ing the immune response. SPP1 is expressed and
secreted by immune cells including T-lymphocytes,
monocytes, macrophages and NK cells. SPP1 is pre-
sumed to regulate the TH1/TH2 balance and apoptosis
[18]. SPP1 polymorphisms are associated with many
immune-mediated inflammatory diseases [19] consistent
with a local immune suppressive state. Quantitative trait
(QTL) analyses in pigs have identified SPP1 as a candi-
date gene for reproductive performance [20].
Alternatively, upregulation of these genes may be an
important mechanism to enhance the response to
Table 1 RT-PCR confirmation of microarray
Fold change Pregnant vs Cyclic Primer Sequences
Microarray RT-PCR Correlation Forward Reverse Probe
OXTR -7.26 -10.55 0.90 cgtgcagatgtggagtgtct ttgcagcagctgttgagg UPL#162
OAS2 10.94 31.05 0.93 tggacggtcaactacagttttg ctgggtccaagatcacagg UPL#69
SPP1 3.41 3.60 0.75 aagttccgccgatctaacg cctcactctctatgtgtgatgtgaa UPL#82
CXCL11 5.23 6.95 0.83 tgctgcaattgttcaaggtt tctgccactttgactgctttt UPL#81
IDO 15.25 28.97 0.76 acgtaggctttgctcttcca gagatccaggcatcataagga UPL#65
Figure 4 RT-PCR confirmation of microarray.
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Page 5 of 13potential viral pathogens that the uterus may encounter
during the time of local immune suppression that
occurs in response to the embryo. This Hypothesis is
supported by the upregulation of MX1 and MX2, both
of which are up-regulated in response to viral infection
[21,22]. MX2 expression is also up-regulated in periph-
eral blood leukocytes during pregnancy [23], suggesting
the innate immune system is active during early
pregnancy.
Several of the above genes are also thought to be
important regulators of luteolysis [21]. For example,
OAS inhibits prostaglandin F2a synthesis, possibly
through alteration of arachidonic acid metabolism [24].
Interestingly, MX2 expression is lower in the uterus of
pregnancies with cloned embryos than in embryos pro-
duced by IVF.
Cytokines, chemokines, and growth factors
Pregnancy requires a delicate balance between pro-
inflammatory and anti-inflammatory molecules to main-
tain maternal immune system integrity, while preventing
rejection of the embryo. Expression patterns of chemo-
kines and their receptors during the implantation period
suggest that they are involved in the regulation of
embryo attachment as well as having immunomodula-
tory properties. Chemokines attract leukocytes to sites
of inflammation, and contribute to their local activation.
Several chemokines were up-regulated in pregnant
animals in agreement with other studies [25-28]. The
CXCR3 ligands CXCL9, CXCL10 and CXCL11 were all
up-regulated in pregnant animals, a difference that is
more pronounced in the caruncular compared with
intercaruncular tissue. CXCR3 is preferentially expressed
on TH1 cells, and the expression of ligands for this
receptor suggests there may be an influx of TH1 cells
into the uterus. Upregulation of the CXCR3 receptor
ligands and the influx of TH1 cells have been associated
with allograft rejection [25,29]. However since CXCR3
was not up-regulated, it suggests that either TH1 cell
numbers were not increased in the uterus of pregnant
animals, or that they were not expressing this receptor.
CXCR3 is also expressed in human uterine natural killer
cells [30], so upregulation of these chemokines may
function to attract the trophoblast and/or uNK cells.
Several chemokines that were up-regulated in pregnant
animals are known to attract immune tolerance promot-
ing leukocytes, including TH2 and NK cells. For exam-
ple, CCL11, which was upregulated in both
intercaruncular and caruncular tissue in pregnant ani-
mals attracts CCR3-expressing TH2 cells [31], and
CCL2, which was only upregulated in caruncular tissue,
attracts leukocytes expressing its receptor CCR2 [31,32].
Consistent with this is the association of CCL2 upregu-
lation with immune tolerance in endometriosis, a
mechanism suggested to act through its action on the
FAS ligand, inducing apoptosis of T lymphocytes [33].
The FAS ligand, along with FAS and the downstream
effector molecules FADD and caspase were all upregu-
lated in pregnant animals in both tissue types. Another
NK cell attracting chemokine up-regulated in pregnant
animals was CCL8 [34]. This chemokines was upregu-
lated 17 fold in the caruncular endometrium, and 9 fold
in the intercaruncular endometrium. In addition to
attracting NK cells, CCL8 can attract monocytes, lym-
phocytes, eosinophils, and basophils through its capacity
to bind to the CCL2 receptor CCR2 as well as CCR1,
CCR3 and CCR5. Both CCR1 and CCR5 were upregu-
lated in caruncular and intercaruncular tissues of preg-
nant animals. Co-expression of proteases that can
convert CCL8 to CCL8(6-75) results in an anti-inflam-
matory response, as CCL8(6-75) can inhibit other che-
mokines through its ability to act as a receptor
antagonist [35].
Several interleukins that were up-regulated in preg-
nant animals may function to increase the presence of
immune tolerance promoting T-regulatory (T-reg) cells
in the uterus, as well as shifting the inflammatory bal-
ance towards an anti-inflammatory response. T-reg cells
require low levels of some cytokines in order to differ-
entiate from naive CD4+ T cell precursors, with high
levels blocking suppression. In particular, IL-15, which
was up-regulated 2 fold in the caruncular endometrium
of pregnant animals. IL-15 also induces proliferation of
T-reg cells [36]. Another cytokine that was up-regulated
in the pregnant endometrium, IL-7, is considered a
growth and survival promoting factor for T-reg cells
[37]. Interleukin1b (IL-1b) and interleukin 18 (IL-18)
are pro-inflammatory cytokines that were up-regulated
in pregnant animals. Caspase 1, which proteolytically
cleaves the IL-1b precursor to its active form, was also
up-regulated in the caruncular endometrium of preg-
nant animals. Inhibitors of these cytokines, IL-1RN and
IL-18BP were also up-regulated in pregnant animals. IL-
1RN has recently been reported to be up-regulated in
the pregnant equine endometrium [38], and down-regu-
lated during the window of implantation in the cyclic
human [39].
The TGFb superfamily is a large functionally diverse
protein family which includes several subfamilies includ-
ing activins, bone morphogenic proteins (BMPs) and
growth differentiation factors (GDF) [40]. Members of
this family were differentially regulated with respect to
pregnancy in the current study including TGFb1, 2 and
3, which were all down-regulated in pregnant animals.
The TGF-b superfamily members have immunomodula-
tory/inflammatory actions, some of which may be
important during pregnancy recognition and mainte-
nance. However, in the current study TGFb1, 2, and 3,
TGFb1I1, and BMP6 were all down-regulated in
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pregnant animals in caruncular endometrium. Other
members of this family that were down-regulated in
pregnancy include; myostatin, Inhibin b A and Inhibin b
B, this is coupled with increased expression of follistatin
(2.8 fold), an inhibitor of both activins and myostatin.
While activins have immunomodulatory actions [41] the
GDF, myostatin has been proposed to have a role in
glucose metabolism [42] in the placenta [43], and in an
endometrial cell line [44]. Myostatin may be an impor-
tant regulator of glucose availability to the embryo
through regulation of glucose in endometrial histotroph
secretions, and later for fetal development through regu-
lation of placental glucose transport. Reduced myostatin
accompanied by increased follistatin indicates that this
pathway is under tight control during early pregnancy.
Antigen presentation and complement related genes
Complement pathway genes are some of the most com-
monly up-regulated genes in this and previous studies of
endometrial gene expression during the window of
implantation [8,45-47]. In particular, several molecules
involved in activation of complement via the classical
pathway were up-regulated in pregnant animals (Figure
3). Upregulation of complement may serve to provide
the developing embryo with protection against patho-
gens and/or immune complexes and apoptotic cells, an
important adaptation given the local immune suppres-
sive state necessary for successful embryo implantation
and placentation. Molecules that protect against comple-
ment mediated cells are expressed in the endometrium
and trophoblast [48]. Consistent with this observation,
pentraxin 3 (PTX3) was up-regulated in pregnant ani-
mals, particularly in the caruncules. PTX3 binding to
the C1q complex can activate or inhibit the classical
complement pathway depending on the nature of the
interaction [49,50]. Upregulation of PTX3 may function
to control the complement cascade in the pregnant ani-
mal and prevent excessive inflammatory reactions.
Another gene that was up-regulated and may function
to inhibit complement mediated immune responses is
SERPING1. SERPING1 is a progesterone-induced,
immunosuppressive and anti-proliferative glycoprotein
contained in uterine secretions [51]. SERPING1 can
inhibit complement-mediated immune responses
through inactivation of C1s. Upregulation of SERPING1
may function to suppress a complement-mediated
immune response to fetal antigens, and may also be
important for embryonic growth. SERPING1 has been
proposed to support conceptus growth through its abil-
ity to sequester the pluripotent growth factor activin A.
Because of its immunosuppressive and anti-proliferative
properties, it has been hypothesized to prevent fetal allo-
graph rejection through inhibition of lymphocyte prolif-
eration in the uterus [51]. Other SERPIN’st h a tw e r e
differentially regulated include; SERPINA9, SERPINA1
and SERPINB11.
Other genes that were up-regulated in pregnant tissue
encode immunoproteasome subunits PSMB8 and
PSMB9, and antigenic peptide transporters TAP1 and
TAP2 [52]. These results identify modulation of the
extent and specificity of antigen presentation as a
mechanism likely required for pregnancy success.
MHC class 1 and class 2 molecules along with B2 M
were identified as being up-regulated in pregnant ani-
mals. Up-regulation of MHC class 1 and B2 M in
response to pregnancy and interferons has been demon-
strated [53,54]. Downregulation of classical MHC class 1
molecules in trophoblast tissue is a well characterized
mechanism proposed to prevent immunological attack
of the embryo [5]. The expression of MHC molecules in
uterine tissue during pregnancy is poorly characterised.
It has been proposed that upregulation of MHC class 1
molecules and B2 M may compensate for loss of mucin
expression in the endometrial luminal epithelium[53].
Mucin-1 (MUC-1) forms part of the glycocalyx barrier
that provides innate immune protection against bacterial
infections; downregulation of MUC-1 is thought to be
required for embryo attachment as the ectoderm tail
presents a steric hindrance to attachment [52]. MUC-1
was down-regulated in pregnant animals in the study
reported here, suggesting this mechanism may be active
in the bovine endometrium also. Furthermore, the non-
classical MHC class 1 molecule HLA-G was up-regu-
lated in pregnant animals, perhaps to support an immu-
nosuppressive action on the maternal immune system.
Antimicrobial response genes
Several antimicrobial genes are up-regulated in the
endometrium of pregnant animals. LBP and BPI, encode
proteins that bind bacterial endotoxin. Both were up-
regulated in pregnant animals, 19 fold and 6 fold respec-
tively, as was the antibacterial gene LYZ1 which was
up-regulated 2.4 fold in pregnant animals. Increased
expression of these genes in pregnant animals may con-
fer innate immune protection against potential bacterial
infection during a time of local immune suppression, as
occurs during pregnancy [55].
Other immune response related genes
Indoleamine -2,3 dioxygenase (IDO) and tryptophanyl-
tRNA synthetase (TTS/WARS) were up-regulated 5.7
fold and 2.4 fold respectively in endometrium of preg-
nant cows’ in the current study. Upregulation of IDO
has been reported in other species [56-58] and is likely
to have an immunosuppressive function in the cow.
Munn et al (1998) described a novel mechanism by
which the maternal system prevents fetal rejection
through increased IDO expression, specifically through
the suppression of T-cell activity. Dendritic cell expres-
sion of IDO causes increased catabolism of the essential
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the tryptophan metabolites 3-OH-Kynurenine and 3-
OH-anthranilic acid. Tryptophan catabolism reduces the
amount of tryptophan available in the microenviron-
ment for protein synthesis, and can thus prevent expan-
sion of T-cells. In addition, tryptophan metabolites have
immunosuppressive properties such that they cause T-
cell apoptosis. Cells expressing IDO are protected
against tryptophan starvation, possibly through expres-
sion of TTS/WARS. TTS is the only known aminoacyl-
tRNA synthetase induced by interferon gamma. The
formation of a tryptophan-tRNA complex results in the
generation of a reservoir of tryptophan that may func-
tion to protect IDO expressing cells from tryptophan
depletion. Upregulation of these genes suggests this
mechanism is active in the pregnant bovine endome-
trium and is likely an important contributor to preg-
nancy success in dairy cattle.
Several galectins were differentially expressed between
pregnant and cyclic animals. Galectin 9 was up-regu-
lated 2.8 fold in pregnant cows while galectin 8 and
galectin 3 binding protein (caruncular only) were up-
regulated 1.7 and 2.2 fold respectively. In contrast,
galectin 12 was down-regulated in pregnant animals (1.6
fold) compared to cyclic animals. Galectins are a family
of lectins that bind to beta-galactoside motifs in ligands
such as laminin, fibronectin, and mucins in bivalent or
multivalent ways, to modulate cellular adhesion [59].
Galectin 3 binding protein (Lgals3bp) can bind to Galec-
tin -1, -3 and -7, promoting cell-cell adhesion through
bridging between galectin molecules bound to ECM
components [60,61]. It can also self-assemble to form
high molecular weight complexes that promote cell
adhesion through binding of integrins, collagens and
fibronectin independently of Galectin 3 [61]. It has been
demonstrated that Galectin-9 administration improves
the survival of allogenic skin grafts in mice, possibly
through induction of host cytotoxic CD8a+ T cell apop-
tosis [62]. Galectin-9 inhibits the secretion of TH1 and
TH17 type cytokines, and promotes the synthesis of
TH2 type cytokines in vitro [63]. Galectin-9 is poten-
tially involved in modulation of the immune system dur-
ing early pregnancy through its ability to induce
apoptosis of immune cells, including activated CD4+
and CD8+ T cells through Ca2+ calpain caspase 1 path-
way [64].
Some of the most highly expressed genes in the preg-
nant animals in this study were guanylate binding pro-
teins (GBP), which belong to a family of GTPases that
also includes Mx proteins (up-regulated in pregnant ani-
mals). GBPs regulate inhibition of proliferation, invasion
of endothelial cells and cell survival. GBPs bind to gua-
nine nucleotides, they contain two binding motifs. GBP-
1 is up-regulated in the human endometrium during the
window of implantation [65], and GBP1 and GBP-3,-4,-
5 are up-regulated in the bovine endometrium at day 18
of pregnancy [10]. Consistent with this premise, GBP-1,-
2,-3,-4 and GBP-6-7 were up-regulated in pregnant ani-
mals in the current study. GBPs are up-regulated in
patients with inflammatory bowel disease (IBD) and also
found to be associated with epithelial tight junctions,
where downregulation of GBP through siRNA causes an
increase in barrier permeability [66]. It has recently
been suggested that the functional significance of GBP
upregulation is to protect cells against pro-inflammatory
cytokine induced apoptosis [66].
Difference in caruncular and intercaruncular endometrial
tissue
The majority of genes differentially expressed between
pregnant and cyclic animals are in both caruncular and
intercaruncular tissues. However, the magnitude of dif-
ferential expression between pregnant and cyclic endo-
metrium differs in the two tissues, and there are some
genes that are only differentially expressed in one of the
t w ot i s s u et y p e s .T h ec a r u ncules of the endometrium
are specialised projections that are the site of embryo
attachment. Caruncules become highly vascularised, and
a r et h em a j o rs i t ef o rs m a l lm o l e c u l ea n dg a s e o u s
exchange[4]. In comparison, intercaruncular tissue is
highly glandular and responsible for early nourishment
of the embryo through secretions of large molecules
into the uterus [67-69]. The magnitude of some of these
gene expression changes differs considerably between
the two tissue types. RSAD2 is the most differentially
expressed gene (23 fold up-regulated in pregnant ani-
mals) in the comparison of pregnant versus cyclic ani-
m a l s .I nt h i sc o m p a r i s o n ,R S A D 2i s3f o l dm o r e
differentially expressed in caruncular than it is in inter-
caruncular tissue. This difference occurs in most of the
genes discussed. The larger difference in gene expres-
sion seen in the caruncular tissue (indicating a greater
response to pregnancy), may reflect the role of this tis-
sue in implantation. The caruncules, being the site of
embryo attachment may demand more extreme gene
expression changes that promote tolerance to the
embryo, allowing it to form a closer physical relation-
ship without immunological attack.
Conclusion
The maternal immune system is actively surveying the
uterine environment during early pregnancy. The
embryo modulates this response, inducing expression of
molecules in the endometrium that function to suppress
the immune response and/or promote tolerance to the
embryo. The current study demonstrates this response
with widespread upregulation of immune response path-
ways. During this period of immune suppression the
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infections; the endometrium must, therefore, actively
express specific molecules for defence against foreign
pathogens. Upregulation of genes of the innate immune
response including antimicrobial response genes support
this hypothesis. This system requires intricate control
through expression of protective inhibitors in the endo-
metrium, and raises the question of whether the embryo
expresses these same inhibitory molecules.
Methods
Animals
All Procedures were undertaken with the approval of
the Ruakura Animal Ethics Committee (Hamilton, New
Zealand). The estrus cycles of 22 lactating dairy cows
were synchronized and 12 of these received embryo
transfer on day 7 of the estrus cycle. Embryos were at
the blastocyst stage of development and of grade 1 qual-
ity. Animals were slaughtered at day 17 of the reproduc-
tive cycle and endometrial tissues (both caruncular and
intercaruncular) were sampled. There were 12 pregnant
and 10 cyclic animals representing mixed New Zealand
and North American ancestry Holstein Friesian dairy
cows. Further details, including production data is pro-
vided in Meier et al 2009[70].
RNA Extraction
Tissues were homogenized in Qiagen buffer RLT (QIA-
GEN GmbH, QIAGEN Strasse 1, 40724 Hilden, Ger-
many) using Fastprep Lysing Matrix D tubes in a
FastPrep instrument (MP Biomedicals, 29525 Fountain
Pkwy, Solon, OH 44139).
Total RNA was extracted using a Qiagen RNeasy kit
(Qiagen). RNA quantity was determined by spectro-
photometry using a Nanodrop ND-1000 (Nanodrop
Technologies, Wilmington, DE). RNA integrity was
assessed with the Agilent 2100 Bioanalyzer with a
RNA 6000 Nano LabChip kit (Agilent Technologies,
Palo Alto, CA).
Microarray
One μgo fR N Aw a sa m p l i f i e du s i n gt h ea m i n oA l l y l
MessageAmp ™ aRNA Kit (Ambion, 2130 Woodward St,
Austin TX, 78744) to generate amino allyl modified
aRNA for use in microarray hybridization. The aRNA
quantity was measured by spectrophotometry using a
ND-1000 (Nanodrop Technologies, Wilmington, DE).
Five μg of aRNA was then vacuum dried and labeled
with Cy3 and Cy5 NHS ester (Amersham Cy3 and Cy5
Mono-Reactive Dye Packs, GE Healthcare UK Ltd., Lit-
tle Chalfont, Buckinghamshire). Labeled aRNA was then
purified on column. Labeling efficiency was determined
by spectrophotometry using the Nanodrop 1000.
825 ng of Cy3 and Cy5 labeled and fragmented aRNA
were added to Agilent 44 k 60-mer oligonucleotide
microarrays (G2514F), hybridized overnight (17 hours),
washed and air dried according to the manufacturer’s
instructions (Agilent Gene Expression Hybridization Kit
60-mer oligo microarray protocol version 4.0). Arrays
were scanned using the Agilent DNA microarray
scanner.
Hybridization design
A total of 44 microarrays were used in this study, one
for each tissue type of the 22 animals. A reference sam-
ple was utilized, made from equal amounts of RNA
from each endometrial sample analyzed (22 caruncular
and 22 intercaruncular samples). This pooled sample
w a su s e da sa‘reference’ in each array hybridization.
The reference sample was labeled with the Cy3 NHS
ester dye, while each individual sample was labeled with
the Cy5 NHS ester dye.
Data analysis and statistics
Agilent feature extraction software version 7.1 was used
to analyse the scanned Agilent microarray. The 44
scanned microarray image files were uploaded to the
feature extraction software. Using a design file (015354),
the feature extraction software locates features and con-
verts the extracted data from each feature into a quanti-
tative log ratio. The software removes pixel outliers,
performs statistical tests on the non outlier pixels, sub-
tracts background from features and flags any outlier
features. The software was then used to perform a
LOWESS (locally weighted linear regression analysis)
dye normalisation and to calculate a p-value for each
feature.
Data analysis was performed with Genespring GX
7 . 3 . 1 .( A g i l e n t ,P a l oA l t o ,C A ,U S A ) .M i c r o a r r a yd a t a
were imported into Genespring using Agilent’st w o -
color ‘Enhanced FE’ import scenario which included ‘Per
Spot: Divide by control channel’ and ‘Per Chip: Normal-
ize to 50th percentile’ normalization steps.
Filters applied to the data to improve the quality of
the normalized dataset included; firstly, filtering ‘on
flags’ to ensure any probes that were not deemed ‘pre-
sent or marginal’ (according to feature extraction spot
quality guidelines) in at least 22 of the 44 arrays were
omitted from analysis; secondly, probes that did not
have a minimum threshold of 80 raw intensity units in
at least 22 of 44 arrays were also omitted from analysis
(15,833 probes passed this filter). The raw intensity cut
off value of 80 was determined based on the base over
proportional (C = a/b) calculation, which is generated
by plotting the standard deviation of normalized values
against the control values. The point at which the curve
flattens out is where the data measurement becomes
reliable or where C (control strength) = a/b (where a =
base and b = the proportional coefficient).
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Page 9 of 13Differentially expressed probes were identified using a
T-Test, including a Benjamini-Hochberg false discovery
rate multiple testing correction (MTC). For probes that
were not annotated, full length transcripts were identi-
fied where possible by querying microarray probe
sequences against the bovine genome (Btau3,1) using
NCBI BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Microarray data was submitted to NCBI gene expression
omnibus (GSE19140).
cDNA Synthesis
One μg of an RNA sample was used for cDNA synthesis
using the Invitrogen Superscript III Supermix kit (Invi-
trogen, Carlsbad, California, USA). Total RNA was tran-
scribed according to the manufacturer’s instructions
using 27 μM of random pentadecamers. Briefly, RNA
and random primers were mixed and denatured at 65°C
for 5 minutes, followed by 1 minute on ice. Annealing
buffer and Superscript/RNase was added to samples and
incubated for 10 minutes at 25°C (primer annealing),
followed by 50 minutes at 50°C and 5 minutes at 85°C
to inactivate the enzyme. Reverse transcription controls
were performed, whereby the above process was com-
pleted without the addition of superscript enzyme.
Quantitative Real Time PCR
Real time PCR using the Roche Lightcycler 480 was per-
formed using the Roche real time PCR master mix
(Lightcycler 480 Probes Master) in combination with
Roche Universal Probe Library (UPL) assays (Roche
diagnostics, Indianapolis, IN, USA). Assays were
designed using Roche UPL design software. All assays
were designed to span an intron-exon boundary.
The PCR reaction volume was 10 μL, consisting of 0.5
μMo fe a c hp r i m e ra n d0 . 1μMo fp r o b e .S t a n d a r d
cycling conditions were used [95°C for 10 minutes,
(95°C for 10 seconds, 60°C for 30 seconds) × 50 cycles,
40°C for 40 seconds].
Each PCR experiment included a reaction in which
template was replaced by water, and a reaction omitting
reverse transcriptase as controls. Triplicate measure-
ments were performed for all samples and standard
curves. The percent coefficient of variation (%CV) for
Cps was calculated for each sample. All samples for
each gene were run on the same plate.
Absolute quantification
The Roche Lightcycler 480 software was used to per-
form absolute quantification analysis of gene expression
using the standard curve second derivative maximum
analysis method, which is a non-linear regression line
method. A six point standard curve was used with a
starting concentration of 1 and final concentration of
1.6E-03.
Relative quantification
The Roche Lightcycler 480 Software was used to per-
form quantification using the ‘advanced relative quantifi-
cation analysis’ algorithm. Two endogenous control
genes were used to normalize the data, taking the geo-
metric mean of the normalized ratio of target gene to
each reference gene [71]. A calibrator sample was then
used as a control, whereby each calculated expression
value was normalized to the calibrator sample.
The RT-PCR results were compared to those obtained
using the microarray for five differentially expressed
genes (OXTR, IDO, SPP1, OAS2, and CXCL11). Corre-
lation coefficients were calculated for all genes to com-
pare the calculated gene expression data from qRT-PCR
and the microarray data. Genes for RT-PCR were
selected based on two criteria. Biological significance
and fold change.
Gene function and pathway identification
Differentially regulated genes were annotated with biolo-
gical and molecular functions using the PANTHER
(Protein ANalysis THrough Evolutionary Relationships)
Classification System (http://www.pantherdb.org/) [72].
Ingenuity pathway analysis (IPA - Ingenuity® Systems,
http://www.ingenuity.com) was used for biological net-
work generation and functional analysis.
Gene lists containing differentially expressed genes for
each comparison (pregnant versus cyclic, caruncular preg-
nant versus caruncular cyclic, and intercaruncular preg-
nant versus intercaruncular cyclic, 1.5 fold differential
expression, P-value ≤ 0.5, Benjamini-Hochberg FDR
MTC) were used for analyses. The human homologue cor-
responding to the bovine gene representing each transcript
identified as being differentially expressed was used.
For Ingenuity pathway analysis, the above gene list
was uploaded and a core analysis was performed. The
default background (ingenuity knowledge base) was used
for all analyses. Each gene in the uploaded list was
assessed for network eligibility (determined by the
representation of the gene in the Ingenuity pathway
knowledge base). Each eligible gene was then mapped
using the data contained within the Ingenuity knowledge
base. Networks were generated based on connectivity of
each of the genes, and a score (p-value calculation) was
assigned based on likelihood that these genes are part of
a network and did not associate due to random chance.
This score was then used to rank each of the generated
networks. Molecules that are known to have direct and
indirect associations were used for network generation.
IPA was also used to identify significant ‘biological
functions’.AF i s c h e r ’s exact test was used to calculate
the probability that the assigned biological function was
not due to random chance.
Walker et al. BMC Genomics 2010, 11:474
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Page 10 of 13Canonical pathways contained within the IPA database
were used to identify pathways that were significantly
enriched in the dataset. The ratio of genes associated
with each canonical pathway to the total number of
genes in that pathway was calculated, and a Fisher’s
exact test was used to test the probability that the asso-
ciation of these genes was significant.
Additional material
Additional file 1: Table S1: List of differentially expressed genes
between pregnant and cyclic animals (≥ 1.5 fold change in
expression; P-value < 0.05, Benjamini-Hochberg MTC).
Additional file 2: Table S2: Top canonical pathways identified using
IPA. *Interferon stimulated genes not previously identified in the bovine
endometrium.
Additional file 3: Table S3: Genes identified as relating to immunity
and defence through PANTHER analysis
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